Showing results (201-210 of 470) with videos related to
Sort By:
Pageof 47
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoiresNaoto Kawakami, Francesca Odoardi, Tjalf Ziemssen, et al.Brain : a Journal of Neurology|October 16, 2004
Neuropathology of white matter disease in Leber's hereditary optic neuropathyGábor G Kovács, Romana Höftberger, Katalin Majtényi, et al.Plos One|May 26, 2011
High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two yearsNermin Serbecic, Fahmy Aboul-Enein, Sven C Beutelspacher, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 21, 2018
Selective Inversion Recovery Quantitative Magnetization Transfer Brain MRI at 7T: Clinical and Postmortem Validation in Multiple SclerosisFrancesca Bagnato, Simon Hametner, Giulia Franco, et al.European Journal of Immunology|June 15, 2010
Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular systemNicolas Prevot, Claire Briet, Hans Lassmann, et al.Brain : a Journal of Neurology|March 19, 2009
Mitochondrial changes within axons in multiple sclerosisDon J Mahad, Iryna Ziabreva, Graham Campbell, et al.Brain : a Journal of Neurology|December 16, 2011
Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 TeslaFrancesca Bagnato, Simon Hametner, Bing Yao, et al.Brain Pathology (Zurich, Switzerland)|December 6, 2003
Differential expression of the chemokine receptors CX3CR1 and CCR1 by microglia and macrophages in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitisDan Sunnemark, Sana Eltayeb, Erik Wallström, et al.Journal of Autoimmunity|January 18, 2020
Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cellsManish Malviya, Abdelhadi Saoudi, Jan Bauer, et al.Journal of Neuroimmunology|September 27, 2003
Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat diseaseSana Eltayeb, Dan Sunnemark, Anna-Lena Berg, et al.Pageof 47